Member Info for Saint68

Lilly would be great - doesn’t get any better than the biggest of BP - could buy us out with few billion of pocket change 👍

HFH- “ A re-engineered CDX making royalty payments to Eli redundant” - don’t think that’s correct. Discussed previously on here.

Cherry picking time frames KP. You more than anyone should stop mocking as it wasn’t that long ago you were bleating that you’d be glad to get your money back here. If you want an Avacta discussion I’m more than happy to oblige but I don’t think JHFH will be pleased.

More data - as informed by CC

Spot on Hiki. Many here are way over exposed and have moaned about it previously. I believe it will become very good but way too many naive people. Investing in early stage pharma is a long process and not for those in a rush.

Https://avacta.wistia.com/s/2hfpqeapla3o5uy

Fair enough and thanks.

How are you so sure LL ? The planned enrolment is 144 patients so 160 seems feasible and gives a little head room if some withdraw.

Thanks to TTB on X for this - https://www.withpower.com/trial/phase-1-adenosquamous-carcinoma-of-the-cervix-2-2026-cd2d6

Suggests 160 patients have been recruited so far.

That is the problem Hiki, many lth had no idea as the website is, quite frankly, sh.t and not a good source for up to date info. Hopefully this will improve.

Don't believe all you read from AI Mike

Trouble is Dhub, not many lth’s visit the website anymore as it’s way out of date. Most of the info is at least a year old. Def a good read though.

Thanks to LTL on Sharediver for this find. https://hemogenyx.com/wp-content/uploads/2026/05/Hemogenyx-Non-confidential-Deck_05-2026.pdf

HFH - “In fact if you invested 5 days ago, a month ago, six months ago or even a year ago, every timestamp has Hemogenyx outperforming them.” - you want to look at that again.

6,321,880 shares then is equivalent to 15,805 shares now.

Daddybear - not sure where you got that information but it's completely wrong. Back in 2020 was before the 400:1 consolidation so the prices were in pennies not pounds ie. £0.0125 not 125p

Hi Socialist.

I have no issue with the board issuing options (within reason) but this is far in excess to what would be classed as normal. We've undoubtedly made great progress over the last year or so and yes some risks have been lessened but some very much still remain.

HFH - "if people aren’t happy, what the **** are you doing here? go and invest somewhere else." - I'm happy with the way the science is progressing and if I wasn't I'd sell. You do know that you can invest in more than one company don't you and that it's ok to discuss negatives and positives on a share BB. Anyone putting all their eggs into an early stage biotech company needs to seek some professional advice.

Sorry Socialist but you're way off the mark with some of your comments.

"...because the company is finally de-risked" - the company is far from being de-risked.

"..They are locking in a high target price: Look at the strike price—it is set at £8.00 per share" - you can't be serious with this comment. The SP has been up to £17 and you think this is a high price. It's taking the p.ss.

"This isn’t a cheap giveaway" - yes it is.

"The price doesn't matter because we don't need the cash." - early pharma companies always need cash and Hemo are no different. The more we have in the bank the better.

Digitt did a great post yesterday on Sharediver - one of the comments was "Again…show me the process they ran that determined that 20% was fair and in line with industry benchmarks. Show me the comp committee deliberating on this and settling on the 20% with that information"

"This 20.7% total pool ensures they are locked in and driving hard toward the finish line." - it's encouraging but to say they're locked in is a stretch as they haven't spent a dime yet.

How many of the board have bought on the open market ? If they were that confident of making millions they could have been buying at £1.40 not that long ago. Why didn't they ?

Similarly they have been in negotiations with BP and will know the numbers being discussed for a potential license deal or takeover.

We know those things are imminent but they are privy to way more info than us -ie all 3 patients doing well and ?? cured. If they suddenly came out with this info it’s bad practice to give everyone this chance to make a killing.